Nick Leschly, Director at bluebird bio, Inc. (BLUE), sold 7,437 shares at $9.40 ($71K) on 2022-01-10, disclosed to the SEC on 2022-01-12.
Seasonal sale ($71k) by Director — this insider has traded BLUE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.40 | 2,369 | $22K | 31.3% |
| 2 | $9.64 | 5,068 | $49K | 68.7% |
| Total | $9.56 avg | 7,437 | $71K | 100% |
| Filing → |
| TSVT | SELL | 2024-01-05 | $560K | — | Filing → |
| TSVT | SELL | 2023-08-24 | $102K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $111K | — | Filing → |